◆ 会议时间：2023年5月17-20日
◆ 会议地点：韩国 首尔
◆ 会议简介：
2023第15届国际系统性红斑狼疮大会暨第43届韩国风湿病学会年会暨第17届国际研讨会(Lupus & KCR 2023)将于2023年5月17-20日在韩国首尔举行。SLE国际大会（LUPUS2023）将重点介绍近期SLE和自身免疫领域在临床、生物学和转化方面的最新进展；大会将包括一个针对实验室科学与临床转化之间联系的特殊计划，包括从B细胞到肾炎的主题的多学科会议，并为展示原始数据提供独特的机会。未经本站许可禁止复制转载摘录本站任何内容-国际医学会议网(lingyuint.com)。
LUPUS & KCR 2023
15th International Congress on Systemic Lupus Erythematosus
43rd Korean College of Rheumatology Annual Scientific Meeting & 17th International Symposium
Date: May 17-20, 2023
Venue:
COEX, Seoul, Korea
摘要征文投稿：
Deadline for Abstract Submission & Modification：
December 2, 2022
Notification of Acceptance：
January 26, 2023
点此提交摘要>>>Submit Abstract>>>
Rules for Submission
All abstracts must be submitted via the Online Submission System ONLY.
The abstract submitter should choose one congress to submit your abstract, either LUPUS 2023 or KCR 2023, in accordance with the topic category.
* Submitted abstracts for LUPUS 2023 will be published in the Lupus Science & Medicine by BMJ. If the abstract submitter does not agree with “BMJ’s standard licence”, the abstract cannot be accepted for submission.
* Submitted abstract for KCR 2023 will be published online as a supplement to the Journal of Rheumatic Diseases.
Abstract submission does not constitute registration in the congress. All abstract presenters must register in LUPUS & KCR 2023.
Authors may edit and modify submitted abstracts until the submission deadline. It is the responsibility of the authors to ensure the accuracy of the abstract. There will be no additional editing after the deadline.
A confirmation letter of the receipt of abstract will be automatically sent to the submitter and the corresponding author by e-mail upon the completion of the on-line submission.
If there is the relevant financial activities outside the submitted work, the corresponding author must complete a disclosure form for potential conflict of interest. A conflict of interest may exist when an author (or author's institution or employer) has financial or personal relationships or affiliations that could influence (or bias) the author's decisions, work, or abstract. The ICMJE Uniform Disclosure Form for Potential Conflict of Interest (www.icmje.org/conflicts-of-interest/) will be used.
Guidelines for Submission
| Language |
English Only |
| Presentation Type |
1) Original Article (Oral or Poster)
2) Case Report (Poster Only) |
| Title |
Only the first letter of the title starts with a capital letter, except the proper nouns. |
| Format |
Original Article – Oral or Poster
Background – Methods – Results - Conclusion
Case Report – Poster only
Case Description - Conclusion |
| Length |
Title : Up to 30 words
Body : Up to 300 words |
| Figure & Table |
Only 1 figure & 1 table is allowed.
* No more than 1 picture, table, graph, or figure should be included in a file. |
| Keywords |
Up to three keywords |
| Funding Source (Optional) |
If you have any funding source to disclose, please state it in ‘Funding Source’ section. |
| Modification |
Available until the deadline of the abstract submission at My Page |
Dear colleagues and friends,
On behalf of the Organizing Committee, it is my great pleasure and honor to invite you to the 15th International Congress on Systemic Lupus Erythematosus and the 43rd Korean College of Rheumatology Annual Scientific Meeting & 17th International Symposium (LUPUS & KCR 2023). It will be held in Seoul, Korea from May 17th to 20th, 2023, co-hosted by Korean Society of Systemic Lupus Erythematosus Research (KSSR) and the Korean College of Rheumatology (KCR).
It is the first time that Korea has been given the honor of hosting this prestigious event and the fifth time the event has been hosted in the Asia-Pacific region after Singapore, Israel, China, and Australia.
“Stairway to the End of the War” is the theme of LUPUS & KCR 2023. It has multiple meanings, one of which is aiming to end the war on rheumatic diseases including SLE. We are hoping that it will also mean the end of war on COVID19 through which the participants could attend the meeting in person. It will gather a huge audience of more than 2,000 participants of rheumatologists from all over the world and world-renowned experts in rheumatic diseases on basic and clinical science.
KSSR is a professional membership organization composed of Korean rheumatologists who have a particular interest in SLE under the KCR. We have been managing most Korean SLE patients and actively performing both basic and clinical research. With over 1,000 members in Korea, KCR is an organization that represents health professionals and scientific societies related to the field of rheumatology. It has contributed to the advancement and promotion of rheumatology in Korea since 1981 and has successfully hosted the annual KCR international symposium since 2006 to strengthen collaboration on rheumatology both domestically and internationally.
This joint meeting of LUPUS & KCR 2023 will expand the scope of programs and topics encompassing and maximizing impacts and synergies. It will be the perfect meeting where you can present your products, discuss with world renowned basic and clinical researchers specialized in rheumatic diseases so that you can connect and collaborate with experts.
I look forward to welcoming you in Seoul in 2023.
With warmest regards
Sang-Cheol Bae, MD, PhD, MPH
Congress Chair, LUPUS & KCR 2023
President, 15th International Congress on Systemic Lupus Erythematosus
President, Korean College of Rheumatology
注册费：
Registration Fee
Regular Registration Deadline April 7, 2023
| Category |
Early Bird Registration |
Regular Registration |
On-site Registration |
| Delegates |
USD 675 |
USD 825 |
USD 975 |
| Delegates from Low Income Countries |
USD 400 |
USD 500 |
USD 600 |
| Trainee |
USD 400 |
USD 500 |
USD 600 |
| Allied Health Care Professional |
USD 400 |
USD 500 |
USD 600 |
| Industry |
USD 1,250 |
USD 1,500 |
USD 1,750 |
| Patient |
USD 50 |
USD 100 |
USD 100 |
| Accompanying Person |
USD 50 |
USD 100 |
USD 150 |
| Gala Dinner |
USD 120 |
N/A |
The Accompanying Person fee is applicable to family members of participants only.
Low Income Countries are based on the World Bank designated country list.
◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|
